Neurofilaments in health and disease.
暂无分享,去创建一个
[1] S. Yang,et al. Protein Kinase FA/Glycogen Synthase Kinase 3α Predominantly Phosphorylates the In Vivo Sites of Ser502, Ser506, Ser603, and Ser666 in Neurofilament , 1995, Journal of neurochemistry.
[2] R. Garruto,et al. Amyotrophic lateral sclerosis and parkinsonism‐dementia on Guam , 1986, Neurology.
[3] M. Mizutani,et al. Defective expression of neurofilament protein subunits in hereditary hypotrophic axonopathy of quail. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[4] Steven H Y Hsieh,et al. Regional modulation of neurofilament organization by myelination in normal axons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[5] Scott T. Brady,et al. Retardation in the slow axonal transport of cytoskeletal elements during maturation and aging , 1989, Neurobiology of Aging.
[6] R. Nixon,et al. Neurofilament phosphorylation: a new look at regulation and function , 1991, Trends in Neurosciences.
[7] D. Fink,et al. Phosphorylation-dependent neurofilament epitopes are reduced at the node of Ranvier , 1992, Journal of neurocytology.
[8] S. Chin,et al. Transfected rat high-molecular-weight neurofilament (NF-H) coassembles with vimentin in a predominantly nonphosphorylated form , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[9] B. Giasson,et al. Aberrant Stress-induced Phosphorylation of Perikaryal Neurofilaments* , 1996, The Journal of Biological Chemistry.
[10] T. Crawford,et al. Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons , 1995, The Journal of cell biology.
[11] K. Chapman,et al. Assembly of microtubules at the tip of growing axons , 1986, Nature.
[12] J. Julien,et al. Multiple phosphorylation sites in mammalian neurofilament polypeptides. , 1982, The Journal of biological chemistry.
[13] L. Descarries,et al. Abnormal perikaryal accumulation of neurofilament light protein in the brain of mice transgenic for the human protein: Sequence of postnatal development , 1995, Neuroscience.
[14] J. Morrison,et al. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Meloche,et al. Inhibition of Growth Factor-induced Protein Synthesis by a Selective MEK Inhibitor in Aortic Smooth Muscle Cells* , 1996, The Journal of Biological Chemistry.
[16] K. Ishiguro,et al. Porcine brain neurofilament-H tail domain kinase: its identification as cdk5/p26 complex and comparison with cdc2/cyclin B kinase. , 1995, Cell motility and the cytoskeleton.
[17] D. Soppet,et al. Evidence for unequal crossing over in the evolution of the neurofilament polypeptide H. , 1992, The Journal of biological chemistry.
[18] James R. Woodgett,et al. Phosphorylation of c-jun mediated by MAP kinases , 1991, Nature.
[19] Veeranna,et al. Neuronal Cyclin‐Dependent Kinase‐5 Phosphorylation Sites in Neurofilament Protein (NF‐H) Are Dephosphorylated by Protein Phosphatase 2A , 1995, Journal of neurochemistry.
[20] N. Hirokawa,et al. Do photobleached fluorescent microtubules move?: re-evaluation of fluorescence laser photobleaching both in vitro and in growing Xenopus axon , 1993, The Journal of cell biology.
[21] J. Trojanowski,et al. Expression of Neurofilament Proteins in the Hypertrophic Granule Cells of Lhermitte-Duclos Disease: An Explanation for the Mass Effect and the Myelination of Parallel Fibers in the Disease State , 1988, Journal of neuropathology and experimental neurology.
[22] D. Cleveland,et al. Expression of NF-L and NF-M in fibroblasts reveals coassembly of neurofilament and vimentin subunits , 1989, The Journal of cell biology.
[23] S. Carpenter. Proximal axonal enlargement in motor neuron disease , 1968, Neurology.
[24] Robert H. Brown,et al. Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice , 1995, Cell.
[25] Y. Hannun,et al. The sphingomyelin cycle and the second messenger function of ceramide. , 1994, The Journal of biological chemistry.
[26] D T Denhardt,et al. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. , 1996, The Biochemical journal.
[27] R. Liem,et al. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments , 1993, The Journal of cell biology.
[28] L. Otvos,et al. Identification of the major multiphosphorylation site in mammalian neurofilaments. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[29] L. Tsai,et al. Differential Cellular Phosphorylation of Neurofilament Heavy Side‐Arms by Glycogen Synthase Kinase‐3 and Cyclin‐Dependent Kinase‐5 , 1996, Journal of neurochemistry.
[30] HM Roder,et al. Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[31] M. Willard,et al. Modulations of neurofilament axonal transport during the development of rabbit retinal ganglion cells , 1983, Cell.
[32] R. Lasek,et al. Axonal transport of the cytoplasmic matrix , 1984, The Journal of cell biology.
[33] J. Julien,et al. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis , 1993, Cell.
[34] H. Pant,et al. cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[35] A. Peterson,et al. Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein , 1994, Neuron.
[36] C. Bergeron,et al. Selective messenger RNA reduction in Alzheimer's disease. , 1988, Brain research.
[37] C. Klee,et al. Superoxide dismutase protects calcineurin from inactivation , 1996, Nature.
[38] R. Nixon,et al. Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber , 1994, The Journal of cell biology.
[39] Scott T. Brady,et al. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells , 1992, Cell.
[40] C. Kaspi,et al. Characterization of Interspecies Size Heterogeneity of the Large Subunit of Mammalian Neurofilaments a , 1985 .
[41] E. Fuchs,et al. Intermediate filaments and disease: mutations that cripple cell strength , 1994, The Journal of cell biology.
[42] Mark A. Smith,et al. Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease , 1995, Journal of neurochemistry.
[43] R. Lazzarini,et al. Age-associated and cell-type-specific neurofibrillary pathology in transgenic mice expressing the human midsized neurofilament subunit , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[44] J. Bains,et al. Axonal atrophy in aging is associated with a decline in neurofilament gene expression , 1995, Journal of neuroscience research.
[45] L. Cork,et al. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease , 1993, Cell.
[46] P M Steinert,et al. Molecular and cellular biology of intermediate filaments. , 1988, Annual review of biochemistry.
[47] R. Nixon,et al. Identification of Ser-55 as a major protein kinase A phosphorylation site on the 70-kDa subunit of neurofilaments. Early turnover during axonal transport. , 1991, The Journal of biological chemistry.
[48] D. Price,et al. Cytoskeletal disorganization induced by local application of β,β′‐iminodipropionitrile and 2,5‐hexanedione , 1983, Annals of neurology.
[49] J. Julien,et al. Delayed Maturation of Regenerating Myelinated Axons in Mice Lacking Neurofilaments , 1997, Experimental Neurology.
[50] W. Schlaepfer. Neurofilaments: structure, metabolism and implications in disease. , 1987, Journal of neuropathology and experimental neurology.
[51] J. Trojanowski,et al. Altered Tau and Neurofilament Proteins in Neuro‐Degenerative Diseases: Diagnostic Implications for Alzheimer's Disease and Lewy Body Dementias , 1993, Brain pathology.
[52] J. Avruch,et al. Sounding the Alarm: Protein Kinase Cascades Activated by Stress and Inflammation* , 1996, The Journal of Biological Chemistry.
[53] J. Julien,et al. The distribution of phosphorylation sites among identified proteolytic fragments of mammalian neurofilaments. , 1983, The Journal of biological chemistry.
[54] J. A. Cromlish,et al. Activation of Cyclic AMP‐Dependent Protein Kinase in Okadaic Acid‐Treated Neurons Potentiates Neurofilament Fragmentation and Stimulates Phosphorylation of Ser2 in the Low‐Molecular‐Mass Neurofilament Subunit , 1996, Journal of neurochemistry.
[55] N. Hirokawa,et al. Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation by tau protein kinase II. , 1993, The Journal of biological chemistry.
[56] M. Carson,et al. ALS, SOD and peroxynitrite , 1993, Nature.
[57] E. Krebs,et al. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. , 1991, The Journal of biological chemistry.
[58] N. Hirokawa,et al. Visualization of Slow Axonal Transport in Vivo , 1996, Science.
[59] J. Eyer,et al. Influence of the phosphorylation state of neurofilament proteins on the interactions between purified filaments in vitro. , 1988, The Biochemical journal.
[60] V. Meininger,et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. , 1994, Human molecular genetics.
[61] M. Somerville,et al. Neurofilament Light and Polyadenylated mRNA Levels Are Decreased in Amyotrophic Lateral Sclerosis Motor Neurons , 1994, Journal of neuropathology and experimental neurology.
[62] J. Gallo,et al. Aggregation of Neurofilaments in NF‐L Transfected Neuronal Cells: Regeneration of the Filamentous Network by a Protein Kinase C Inhibitor , 1996, Journal of neurochemistry.
[63] J. Rossant,et al. The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1 , 1995, Nature Genetics.
[64] D. Bredesen,et al. Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.
[65] P. D’Eustachio,et al. Structure and evolutionary origin of the gene encoding mouse NF-M, the middle-molecular-mass neurofilament protein. , 1987, European journal of biochemistry.
[66] N. Hirokawa,et al. Dynamics of the neuronal intermediate filaments , 1993, The Journal of cell biology.
[67] R. Nixon,et al. The Regulation of Neurofilament Protein Dynamics by Phosphorylation: Clues to Neurofibrillary Pathobiology , 1993, Brain pathology.
[68] M. Kirschner,et al. Microtubule behavior in the growth cones of living neurons during axon elongation , 1991, The Journal of cell biology.
[69] D. Cleveland,et al. A mutant neurofilament subunit causes massive, selective motor neuron death: Implications for the pathogenesis of human motor neuron disease , 1994, Neuron.
[70] A. Barzilai,et al. Distinctly Phosphorylated Neurofilaments in Different Classes of Neurons , 1994, Journal of neurochemistry.
[71] M. Tabaton,et al. Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[72] E. Fuchs,et al. Gene targeting of BPAG1: Abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration , 1995, Cell.
[73] J. Griffin,et al. Phosphorylation-related immunoreactivity and the rate of transport of neurofilaments in chronic 2,5-hexanedione intoxication , 1991, Brain Research.
[74] R. Nixon,et al. Differential turnover of phosphate groups on neurofilament subunits in mammalian neurons in vivo. , 1986, The Journal of biological chemistry.
[75] R. Lasek. Polymer Sliding in Axons , 1986, Journal of Cell Science.
[76] G. Bennett,et al. Identification of Ser‐Pro and Thr‐Pro Phosphorylation Sites in Chicken Neurofilament‐M Tail Domain , 1997, Journal of neurochemistry.
[77] H. Durham,et al. Activation of Protein Kinase C Induces Neurofilament Fragmentation, Hyperphosphorylation of Perikaryal Neurofilaments and Proximal Dendritic Swellings in Cultured Motor Neurons , 1996, Journal of neuropathology and experimental neurology.
[78] Veeranna,et al. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[79] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[80] J. Julien,et al. Neurofilaments and motor neuron disease. , 1997, Trends in cell biology.
[81] M. Gurney,et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[82] T. Crawford,et al. Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport , 1996, The Journal of cell biology.
[83] M. Nagao,et al. Neurofilament-associated protein phosphatase 2A: its possible role in preserving neurofilaments in filamentous states. , 1995, Biochemistry.
[84] Jeffrey A. Cohen,et al. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons , 1993, The Journal of comparative neurology.
[85] R. Lasek,et al. The slow component of axonal transport. Identification of major structural polypeptides of the axon and their generality among mammalian neurons , 1975, The Journal of cell biology.
[86] M. Strong. Aluminum neurotoxicity: An experimental approach to the induction of neurofilamentous inclusions , 1994, Journal of the Neurological Sciences.
[87] E. Fuchs,et al. An Essential Cytoskeletal Linker Protein Connecting Actin Microfilaments to Intermediate Filaments , 1996, Cell.
[88] N. Hirokawa,et al. Molecular architecture of the neurofilament. II. Reassembly process of neurofilament L protein in vitro. , 1990, Journal of molecular biology.
[89] L. Bruijn,et al. Sequence variants in human neurofilament proteins: Absence of linkage to familial amyotrophic lateral sclerosis , 1996, Annals of neurology.
[90] M. Black,et al. Newly assembled microtubules are concentrated in the proximal and distal regions of growing axons , 1992, The Journal of cell biology.
[91] S. Sasaki,et al. Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis , 1996, Neurology.
[92] J. A. Cohlberg,et al. Neurofilament Protein Heterotetramers as Assembly Intermediates (*) , 1995, The Journal of Biological Chemistry.
[93] V. Massey,et al. Mechanistic studies of p-hydroxybenzoate hydroxylase reconstituted with 2-Thio-FAD. , 1983, The Journal of biological chemistry.
[94] F. Grosveld,et al. Sequence and structure of the mouse gene coding for the largest neurofilament subunit. , 1988, Gene.
[95] L. Cork,et al. Alterations in neurofilament mRNA in hereditary canine spinal muscular atrophy. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[96] J. Julien,et al. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis , 1995, Nature.
[97] H. Roder,et al. Phosphatase Resistance of ERK2 Brain Kinase PK40erk2 , 1995, Journal of neurochemistry.
[98] J. H. Wang,et al. Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2. , 1992, The Journal of biological chemistry.
[99] J Q Trojanowski,et al. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. , 1991, The American journal of pathology.
[100] G. Rouleau,et al. Analysis of the KSP repeat of the neurofilament heavy subunit in familial amyotrophic lateral sclerosis , 1996, Neurology.
[101] B. Khatra,et al. Phosphorylation of bovine neurofilament proteins by protein kinase FA (glycogen synthase kinase 3). , 1991, The Journal of biological chemistry.
[102] L. Sternberger,et al. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[103] P. Wong,et al. Neurofilaments are obligate heteropolymers in vivo , 1993, The Journal of cell biology.
[104] T. Kishimoto,et al. Phosphorylation of neurofilament H subunit at the tail domain by CDC2 kinase dissociates the association to microtubules. , 1991, The Journal of biological chemistry.
[105] Guy A. Rouleau,et al. SOD1 mutation is assosiated with accumulation of neurofilaments in amyotrophic lateral scelaries , 1996 .
[106] F. Cacucci,et al. Early upregulation of medium neurofilament gene expression in developing spinal cord of the wobbler mouse mutant. , 1996, Brain research. Molecular brain research.
[107] R. Lazzarini,et al. The structure and organization of the human heavy neurofilament subunit (NF‐H) and the gene encoding it. , 1988, The EMBO journal.
[108] D. Plummer,et al. Giant axonal neuropathy: a conditional mutation affecting cytoskeletal organization , 1985, The Journal of cell biology.
[109] M. Beal,et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.
[110] M. Sacher,et al. Okadaic acid induces the rapid and reversible disruption of the neurofilament network in rat dorsal root ganglion neurons. , 1992, Biochemical and biophysical research communications.
[111] D. Borchelt,et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.
[112] S. M. Chou,et al. Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study , 1996, Journal of Chemical Neuroanatomy.
[113] R. Burgoyne. The Neuronal cytoskeleton , 1992 .
[114] H. Gainer,et al. Identification of Endogenously Phosphorylated KSP Sites in the High‐Molecular‐Weight Rat Neurofilament Protein , 1994, Journal of neurochemistry.
[115] E. Tanaka,et al. Making the connection: Cytoskeletal rearrangements during growth cone guidance , 1995, Cell.
[116] J. Trojanowski,et al. Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.